Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(9 sites)

United Kingdom

Addenbrooke's Hospital, Cambridge, Cambridgeshire

Royal Devon University Healthcare Foundation Trust, Exeter, Devon

Ninewells hospital and Medical School, Dundee, Dundee

Kent & Canterbury Hospital, Canterbury, Kent

Guy's and St Thomas' NHS Foundation Trust, London, London

The Royal Marsden NHSFT, London, London

St James's University hospital, Leeds, Yorkshire

St Bartholomew's Hospital, London

University College London Hospital NHS Foundation Trust, London